CSI Market
Sign In | Register

Bio techne (TECH) Annual Income Statement

Annual · GAAP · USD millions
Access TECH quarterly income statements →
This page allows investors to track Bio techne's income statement performance across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
2026 		(Jun 30 2025) (Jun 30 2024) (Jun 30 2023) (Jun 30 2022)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax1,215.04
Total Revenue1,215.04
Costs & Expenses
Cost of Goods and Services Sold415.97
Gross Profit0.00
Selling, Administration, Marketing452.42
Depreciation & Amortization195.35
Research and Development Expense (Excluding Acquired in Process Cost)94.77
Other Operating Expense / -Income0.00
Unusual Expense / Income5.50
Total operating costs including COS547.18
Operating income / -loss251.89
Interest Expense0.00
Net Interest Expense / -Income0.00
Investment Income, Interest and Dividend-0.75
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes240.68
Income taxes expenses / -benefit58.82
Income after income taxes181.86
Net income / -loss of other equity0.00
Income / -loss from continuing operations181.86
Non-controlling interests0.00
Net income / -loss181.86
Income / -loss to shareholder181.84
EBIT240.68
EBITD301.51
EBITDA363.29
Earnings Per Share
Basic EPS (excl. extra items)1.17
Basic Net EPS1.17
Basic shares outstanding (Mill. of Units)155.96
Diluted Net EPS1.16
Diluted average shares (Mill. of Units)157.01
Dividend per share0.32
4 historic quarters locked

Sign in to unlock the full Bio techne income statement history.

Sign In Create Free Account

About Bio Techne Corp Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.